Full description
This collection of data is from four experimental trials between 2019 and 2022, investigating the effect of the immune stimulant Amplimune® (NovaVive Inc., Napanee, Ontario, Canada) on immune and physiological responses in Australian beef cattle. The aim was to explore the potential of the immune stimulant to enhance immune responses and protect cattle against a range of pathogens. At CSIRO’s Chiswick Research Station near Armidale, NSW, immune and physiological responses were measured following administration of Amplimune to cattle in vivo (live animal), or cattle immune cells in vitro (in the laboratory). Immune responses were measured using a haematological analyser, enzyme-linked immunosorbent assays, cell culture and RNA extraction, PCR and sequencing. Physiological responses were measured using temperature loggers, weight scales and physical assessment (by a veterinarian). These data (except the sequencing data) were all stored in excel spreadsheets. The sequencing data was stored as zipped fastq files.Issued: 2023-06-16
Spatial Coverage And Location
text: Armidale, NSW, Australia
Subjects
Agricultural and Veterinary Sciences |
Amplimune |
Cattle |
Immune stimulants |
Innate immunity |
Trained immunity |
Veterinary Sciences |
Veterinary Immunology |
feedlot |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Other Information
Identifiers
- DOI : 10.25952/2BY7-VV53
- Handle : 1959.11/56759
- Local : une:1959.11/56759
